These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24900265)

  • 61. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
    Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
    J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.
    Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM
    Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phenotypic analysis of chemokine-driven actin reorganization in primary human neutrophils.
    Kredel S; Wolff M; Gierschik P; Heilker R
    Assay Drug Dev Technol; 2014 Mar; 12(2):120-8. PubMed ID: 24579814
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel phenylcyclohex-1-enecarbothioamide derivative inhibits CXCL8-mediated chemotaxis through selective regulation of CXCR2-mediated signalling.
    Ha H; Bensman T; Ho H; Beringer PM; Neamati N
    Br J Pharmacol; 2014 Mar; 171(6):1551-65. PubMed ID: 24354854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2.
    Lippert U; Zachmann K; Henz BM; Neumann C
    Exp Dermatol; 2004 Aug; 13(8):520-5. PubMed ID: 15265017
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.
    Heidemann J; Ogawa H; Dwinell MB; Rafiee P; Maaser C; Gockel HR; Otterson MF; Ota DM; Lugering N; Domschke W; Binion DG
    J Biol Chem; 2003 Mar; 278(10):8508-15. PubMed ID: 12496258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.
    Khurram SA; Bingle L; McCabe BM; Farthing PM; Whawell SA
    J Oral Pathol Med; 2014 Oct; 43(9):667-74. PubMed ID: 24965032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo.
    Falsone A; Wabitsch V; Geretti E; Potzinger H; Gerlza T; Robinson J; Adage T; Teixeira MM; Kungl AJ
    Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23919527
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2.
    Denisov SS; Ippel JH; Heinzmann ACA; Koenen RR; Ortega-Gomez A; Soehnlein O; Hackeng TM; Dijkgraaf I
    J Biol Chem; 2019 Aug; 294(33):12370-12379. PubMed ID: 31235521
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
    Nicholson GC; Tennant RC; Carpenter DC; Sarau HM; Kon OM; Barnes PJ; Salmon M; Vessey RS; Tal-Singer R; Hansel TT
    Pulm Pharmacol Ther; 2007; 20(1):52-9. PubMed ID: 16406722
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
    Goldblatt J; Lawrenson RA; Muir L; Dattani S; Hoffland A; Tsuchiya T; Kanegasaki S; Sriskandan S; Pease JE
    J Immunol; 2019 Jun; 202(11):3246-3255. PubMed ID: 31010851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CXCR2 receptor antagonists: a medicinal chemistry perspective.
    Dwyer MP; Yu Y
    Curr Top Med Chem; 2014; 14(13):1590-605. PubMed ID: 25159161
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
    Feniger-Barish R; Ran M; Zaslaver A; Ben-Baruch A
    Cytokine; 1999 Dec; 11(12):996-1009. PubMed ID: 10623425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The activation of IL-8 receptors in cultured guinea pig Müller glial cells is modified by signals from retinal pigment epithelium.
    Malgorzata Goczalik I; Raap M; Weick M; Milenkovic I; Heidmann J; Enzmann V; Wiedemann P; Reichenbach A; Francke M
    J Neuroimmunol; 2005 Apr; 161(1-2):49-60. PubMed ID: 15748943
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
    Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
    Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites.
    Attal H; Cohen-Hillel E; Meshel T; Wang JM; Gong W; Ben-Baruch A
    Exp Cell Res; 2008 Jan; 314(2):352-65. PubMed ID: 17996233
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway.
    Li MQ; Luo XZ; Meng YH; Mei J; Zhu XY; Jin LP; Li DJ
    Hum Reprod; 2012 Jul; 27(7):2107-16. PubMed ID: 22563025
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Amphibian (
    Koubourli DV; Yaparla A; Popovic M; Grayfer L
    Front Immunol; 2018; 9():2058. PubMed ID: 30258441
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling.
    Müller-Edenborn B; Frick R; Piegeler T; Schläpfer M; Roth-Z'graggen B; Schlicker A; Beck-Schimmer B
    Br J Anaesth; 2015 Jan; 114(1):143-9. PubMed ID: 24989774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.